Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R Sterling

Showing results (1-10 of 742) with videos related to

Pageof 75
Sort By:
The Hopkins HIV Report : a Bimonthly Newsletter for Healthcare Providers|May 13, 2003
Treatment of tuberculosis in the HIV-infected patientTimothy R Sterling
The International Journal of Tuberculosis and Lung Disease : the Official Journal of the International Union Against Tuberculosis and Lung Disease|January 8, 2005
The WHO/IUATLD diagnostic algorithm for tuberculosis and empiric fluoroquinolone use: potential pitfallsT R Sterling
Seminars in Respiratory and Critical Care Medicine|September 24, 2008
New approaches to the treatment of latent tuberculosisTimothy R Sterling
The Hopkins HIV Report : a Bimonthly Newsletter for Healthcare Providers|August 20, 2002
Snapshot from Durban: initiation of antiretroviral therapyT R Sterling
The Journal of Protozoology|February 1, 1972
Ultrastructural study of gametocytes and gametogenesis of Haemoproteus metchnikoviC R Sterling
Journal of Medical Microbiology|March 9, 2000
Cryptosporidiosis: the treatment dilemmaCharles R Sterling
The Hopkins HIV Report : a Bimonthly Newsletter for Healthcare Providers|August 20, 2002
Adherence to antiretroviral therapyT R Sterling
The Hopkins HIV Report : a Bimonthly Newsletter for Healthcare Providers|May 28, 2002
When to start HAART: still a controversy. Report from Seattle: the 9th Conference on Retroviruses and Opportunistic Infections (CROI)Timothy R Sterling
The International Journal of Tuberculosis and Lung Disease : the Official Journal of the International Union Against Tuberculosis and Lung Disease|February 28, 2017
Fluoroquinolones for the treatment and prevention of multidrug-resistant tuberculosisT R Sterling
Evidence-Based Medicine|May 1, 2015
Four-month fluoroquinolone-containing regimens are inferior to standard 6-month tuberculosis treatmentTimothy R Sterling
Pageof 75

Showing results (1-10 of 742) with videos related to

Sort By:
Pageof 75
The Hopkins HIV Report : a Bimonthly Newsletter for Healthcare Providers|May 13, 2003
Treatment of tuberculosis in the HIV-infected patientTimothy R Sterling
The International Journal of Tuberculosis and Lung Disease : the Official Journal of the International Union Against Tuberculosis and Lung Disease|January 8, 2005
The WHO/IUATLD diagnostic algorithm for tuberculosis and empiric fluoroquinolone use: potential pitfallsT R Sterling
Seminars in Respiratory and Critical Care Medicine|September 24, 2008
New approaches to the treatment of latent tuberculosisTimothy R Sterling
The Hopkins HIV Report : a Bimonthly Newsletter for Healthcare Providers|August 20, 2002
Snapshot from Durban: initiation of antiretroviral therapyT R Sterling
The Journal of Protozoology|February 1, 1972
Ultrastructural study of gametocytes and gametogenesis of Haemoproteus metchnikoviC R Sterling
Journal of Medical Microbiology|March 9, 2000
Cryptosporidiosis: the treatment dilemmaCharles R Sterling
The Hopkins HIV Report : a Bimonthly Newsletter for Healthcare Providers|August 20, 2002
Adherence to antiretroviral therapyT R Sterling
The Hopkins HIV Report : a Bimonthly Newsletter for Healthcare Providers|May 28, 2002
When to start HAART: still a controversy. Report from Seattle: the 9th Conference on Retroviruses and Opportunistic Infections (CROI)Timothy R Sterling
The International Journal of Tuberculosis and Lung Disease : the Official Journal of the International Union Against Tuberculosis and Lung Disease|February 28, 2017
Fluoroquinolones for the treatment and prevention of multidrug-resistant tuberculosisT R Sterling
Evidence-Based Medicine|May 1, 2015
Four-month fluoroquinolone-containing regimens are inferior to standard 6-month tuberculosis treatmentTimothy R Sterling
Pageof 75